LENNOX GASTAUT SYNDROME
Clinical trials for LENNOX GASTAUT SYNDROME explained in plain language.
Never miss a new study
Get alerted when new LENNOX GASTAUT SYNDROME trials appear
Sign up with your email to follow new studies for LENNOX GASTAUT SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
CBD epilepsy drug under Real-World watch for rare seizure disorders
Disease control OngoingThis study follows about 111 people with Lennox-Gastaut syndrome, Dravet syndrome, or tuberous sclerosis complex who are taking Epidyolex (a CBD oral solution) for seizures. Researchers track how many stay on the drug for a year and how many seizure-free days they have. It's an o…
Matched conditions: LENNOX GASTAUT SYNDROME
Sponsor: Jazz Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Brain pacemaker shows promise for rare childhood epilepsy
Disease control OngoingThis pilot study tests whether deep brain stimulation (DBS) of specific brain pathways can safely reduce seizures in people with Lennox-Gastaut syndrome, a severe form of epilepsy. Five participants receive the electrical stimulation as an add-on to their usual treatment. The goa…
Matched conditions: LENNOX GASTAUT SYNDROME
Phase: NA • Sponsor: Liankun_Ren • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Brain implant shows promise for Hard-to-Treat seizures in rare epilepsy
Disease control OngoingThis study tests a brain-responsive neurostimulation system in 24 people aged 12 and older with Lennox-Gastaut syndrome whose seizures are not controlled by medication. The device detects and responds to seizure activity in the brain to reduce drop seizures. The goal is to see if…
Matched conditions: LENNOX GASTAUT SYNDROME
Phase: PHASE2 • Sponsor: NeuroPace • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Bridge program keeps seizure drug available for eligible patients
Disease control NO_LONGER_AVAILABLEThis program provides continued access to the seizure medication perampanel (Fycompa) for people who completed certain earlier studies and are still benefiting from the drug. It runs until the drug is commercially available in their country or no participants remain. Only those a…
Matched conditions: LENNOX GASTAUT SYNDROME
Sponsor: Eisai Inc. • Aim: Disease control
Last updated Jun 26, 2026 17:19 UTC
-
Epidiolex liver check: is Long-Term use safe?
Knowledge-focused OngoingThis study follows 154 people taking Epidiolex (cannabidiol) for seizures caused by Lennox-Gastaut syndrome, Dravet syndrome, or tuberous sclerosis complex. Researchers will monitor for signs of chronic liver injury and fibrosis over time using blood tests and liver scans. The go…
Matched conditions: LENNOX GASTAUT SYNDROME
Phase: PHASE4 • Sponsor: Jazz Pharmaceuticals • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC